242 related articles for article (PubMed ID: 2938530)
1. The toxicity of D-penicillamine in systemic sclerosis.
Steen VD; Blair S; Medsger TA
Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
[TBL] [Abstract][Full Text] [Related]
3. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
[TBL] [Abstract][Full Text] [Related]
4. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
[TBL] [Abstract][Full Text] [Related]
5. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
Essigman WK
Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
[TBL] [Abstract][Full Text] [Related]
6. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
Davis P; Bleehen SS
Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
[No Abstract] [Full Text] [Related]
7. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
Raynauld JP; Lee YS; Kornfeld P; Fries JF
J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
[TBL] [Abstract][Full Text] [Related]
8. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
[TBL] [Abstract][Full Text] [Related]
9. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
Andonopoulos AP; Terzis E; Tsibri E; Papasteriades CA; Papapetropoulos T
Clin Rheumatol; 1994 Dec; 13(4):586-8. PubMed ID: 7697959
[TBL] [Abstract][Full Text] [Related]
10. [Penicillamine: its use in rheumatoid arthritis].
Colombo B; Gerloni V
Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
[No Abstract] [Full Text] [Related]
11. D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis.
Ciompi ML; Marchetti G; Bazzichi L; Puccetti L; Agelli M
Rheumatol Int; 1995; 15(3):95-7. PubMed ID: 8588126
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
[TBL] [Abstract][Full Text] [Related]
13. [D-penicillamine-induced myasthenia gravis].
Frey RA; Keller F; Michel BA
Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
[TBL] [Abstract][Full Text] [Related]
14. D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings.
Drosos AA; Christou L; Galanopoulou V; Tzioufas AG; Tsiakou EK
Clin Exp Rheumatol; 1993; 11(4):387-91. PubMed ID: 8403583
[TBL] [Abstract][Full Text] [Related]
15. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
17. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Dahlqvist SR; Ström H; Bjelle A; Möller E
Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
Bucknall RC; Dixon A St J; Glick EN; Woodland J; Zutshi DW
Br Med J; 1975 Mar; 1(5958):600-2. PubMed ID: 1125624
[TBL] [Abstract][Full Text] [Related]
19. Sequential gold and penicillamine therapy in rheumatoid arthritis.
Halla JT; Cassady J; Hardin JG
Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
[TBL] [Abstract][Full Text] [Related]
20. The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
Muirden KD
Med J Aust; 1986 Jan; 144(1):32-4, 36-7. PubMed ID: 2867456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
